In ccRCC tumors, the loss-of-function mutations of von Hippel–Lindau tumor suppressor (VHL), an E3 ubiquitin ligase that targets HIF1α under normoxic conditions, are usually responsible for hypoxia response activation (22, 23). Here, VHL is linked to nonpapillary renal cell carcinoma.